Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction | MicrobiomeTrials← Back to trialsNCT06652087
Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-09-02Est. Completion: 2026-09-30
Enrollment target: 40 participants Other microbiome trials you might be interested in
Irritable Bowel Syndrome - Diarrhoea
The goal of this clinical trial is to learn if Bifidobacterium. animalis subsp.
Lactis A6 Strain or resveratrol to impr…
Beijing, ChinaCompleted Mar 31, 2025
Irritable Bowel Syndrome (IBS)Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
The goal of this clinical trial is to learn if an herbal supplement called Biocidin REMOVE can clear small intestinal ba…
Baltimore, United StatesEst. completion Dec 31, 2027
Recruiting
Small Intestinal Bacterial OvergrowthSIBO
The goal of this study is to test the effect of a probiotic formulation on gastrointestinal symptoms, gut and small inte…
Calgary, CanadaEst. completion Apr 2027